{"originalText": "，缘于3月前因“反复进食受阻2月余。”为主诉入院，诊断食管占位，排除手术禁忌症后于2016-01-20在全麻上行胸腔镜上全胸段食管切除+食管-胃底右颈部吻合术，术顺，术后恢复可，术后病理（201602316），：(食管及胃底)，：食管溃疡型鳞状细胞癌II级，侵及外膜层，手术标本下、上切端均未见癌浸润，找到胃周淋巴结1/17个，另送(隆突上)淋巴结0/2个、(右喉返喉返神经旁)淋巴结0/8个、(左喉返喉返神经旁)淋巴结个0/5、(右锁骨下)淋巴结0/4个、(下段食管旁)淋巴结0/1个、(颈段食管旁)淋巴结0/2个、(上段食管旁)个淋巴结0/1个，见癌转移。排除化疗禁忌症后于2016.02.19、2016.03.13、2016.04.08以“顺铂40MGD1-2，紫杉醇（泰素）180MGD2”行化疗，辅以保肝、护胃、提高免疫力等处理，未见明显化疗副反应，现为求第4期化疗，就诊我院，门诊拟“食管癌术后化疗后”收住入院，自出院以来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 27, "end_pos": 31}, {"label_type": "手术", "overlap": 0, "start_pos": 56, "end_pos": 79}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 115, "end_pos": 128}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 325, "label_type": "药物", "overlap": 0, "start_pos": 323}, {"end_pos": 337, "label_type": "药物", "overlap": 0, "start_pos": 334}, {"end_pos": 340, "label_type": "药物", "overlap": 0, "start_pos": 338}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 398, "end_pos": 403}]}
